Clinical proof of concept for a safe and effective NF-κB-targeting strategy in multiple myeloma

Laura Tornatore, Daria Capece, Daniel D'Andrea, Federica Begalli, Daniela Verzella, Jason Bennett, Gary Acton, Elizabeth A. Campbell, James Kelly, Michael Tarbit, Nigel Adams, Selina Bannoo, Antonio Leonardi, Annamaria Sandomenico, Domenico Raimondo, Menotti Ruvo, Angela Chambery, Metod Oblak, Magda J. Al-Obaidi, Richard S. KaczmarskiIan Gabriel

Research output: Contribution to journalLetterpeer-review

15 Citations (Scopus)

Abstract

Despite the recent introduction of new treatments and improvements in clinical outcomes, multiple myeloma (MM) remains a medical problem
Original languageEnglish
Pages (from-to)588-592
Number of pages5
JournalBritish Journal of Haematology
Volume185
Issue number3
Early online date26 Sept 2018
DOIs
Publication statusPublished - May 2019
Externally publishedYes

Bibliographical note

Free access

Keywords

  • NF-kB
  • multiple myeloma
  • clinical trials
  • drug
  • apoptosis
  • NF-κB

ASJC Scopus subject areas

  • Hematology

Fingerprint

Dive into the research topics of 'Clinical proof of concept for a safe and effective NF-κB-targeting strategy in multiple myeloma'. Together they form a unique fingerprint.

Cite this